NCT04499664

Brief Summary

The function of the autonomic nervous system can be assessed using baroreflex sensitivity (BRS) and heart rate variability (HRV). Decreased HRV has been shown to be predictive of morbidity and mortality in diverse medical conditions such as acute myocardial infarction, aneurysmal subarachnoid haemorrhage, autoimmune diseases, sepsis and surgery. The function of the autonomic nervous system has not yet been investigated in a "pure hypovolemia" model. The aim of the current study is therefore to investigate and describe the function of the autonomic nervous system prior to, during and after reduction of blood volume in healthy blood donors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 31, 2020

Completed
1 day until next milestone

Study Start

First participant enrolled

August 1, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 5, 2020

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

August 30, 2022

Status Verified

August 1, 2022

Enrollment Period

1 month

First QC Date

July 31, 2020

Last Update Submit

August 29, 2022

Conditions

Keywords

Heart rate variabiltyBaroreceptor sensitivityAutonomic nervous systemAcute blood lossBlood donorsAutonomic cardiovascular control

Outcome Measures

Primary Outcomes (1)

  • Changes in root mean square of successive NN-interval differences (RMSSD) during mobilisation

    Measured in ms

    15 minutes prior to and 15 minutes after blood donation

Secondary Outcomes (32)

  • Changes in root mean square of successive NN-interval differences (RMSSD) during sleep

    The night before and night after blood donation

  • Changes in standard deviation of N-N intervals (SDNN) during mobilisation

    15 minutes prior to and 15 minutes after blood donation

  • Changes in standard deviation of N-N intervals (SDNN) during sleep

    The night before and night after blood donation

  • Percentage of successive RR intervals that differ by more than 50 ms (pNN50) during mobilisation

    15 minutes prior to and 15 minutes after blood donation

  • Percentage of successive RR intervals that differ by more than 50 ms (pNN50) during sleep

    The night before and night after blood donation

  • +27 more secondary outcomes

Other Outcomes (1)

  • Pain score

    15 minutes prior to and 15 minutes after blood donation

Study Arms (1)

Blood donors

Healhy young male bloddonors, aged 30-45

Device: Monitoring of the autonomic nervous system

Interventions

Monitoring of the autonomic nervous system using E-patch, LiDCO and Root-Massimo.

Blood donors

Eligibility Criteria

Age30 Years - 45 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Healthy male volonteers, aged 30-45, that are eligable for blood donation following the Danish legislation

You may qualify if:

  • Volonteers eligable for blood donation following the Danish legislation
  • Male
  • Age 30-45
  • Written informed consent
  • Speak and understand Danish

You may not qualify if:

  • Volonteers not eligable for blood donation following the Danish legislation, among others due to:
  • Alcohol and drug abuse
  • Cognitive dysfunction
  • Use of anxiolytic or antipsychotic drugs
  • Arrhythmias or heart failure
  • Diabetes mellitus type I
  • Diabetes mellitus type II
  • Use of opioids
  • History of following diseases in the autonomic nervous system: Parkinson disease, multiple sclerosis, autonomic neuropathies
  • History of cerebral apoplexy or transitory cerebral ischemia
  • Dementia
  • American Society of Anesthesiologists (ASA) score ≥ 4
  • Furthermore:
  • History of orthostatic intolerance and/or orthostatic hypotension
  • Use of following vasodilator antihypertensive drugs: beta-blockers, angiotensin converting enzyme inhibitors (ACEI), angiotensin 2 receptor blockers (ARBs), calcium channel blockers
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hvidovre University Hospital

Copenhagen, 2960, Denmark

Location

Related Publications (1)

  • Hristovska AM, Uldall-Hansen B, Mehlsen J, Andersen LB, Kehlet H, Foss NB. Orthostatic intolerance after acute mild hypovolemia: incidence, pathophysiologic hemodynamics, and heart-rate variability analysis-a prospective observational cohort study. Can J Anaesth. 2023 Oct;70(10):1587-1599. doi: 10.1007/s12630-023-02556-6. Epub 2023 Sep 26.

Biospecimen

Retention: SAMPLES WITH DNA

10 mL of blood stored in a biobank

MeSH Terms

Conditions

Primary DysautonomiasHemorrhage

Condition Hierarchy (Ancestors)

Autonomic Nervous System DiseasesNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Henrik Kehlet, Professor

    Rigshospitalet, Denmark

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

July 31, 2020

First Posted

August 5, 2020

Study Start

August 1, 2020

Primary Completion

September 1, 2020

Study Completion

June 1, 2022

Last Updated

August 30, 2022

Record last verified: 2022-08

Locations